New catheter study tracks targeted chemo delivery for solid tumors

NCT ID NCT06805461

First seen Nov 01, 2025 · Last updated Jun 16, 2026 · Updated 29 times

Summary

This study is collecting information from 1,000 people with solid tumors who receive chemotherapy through a special catheter called RenovoCath, which delivers drugs directly to the tumor site. Researchers are tracking safety, side effects, and survival over time. The goal is to learn how well this targeted delivery method works in real-world use.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SOLID TUMORS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Baptist Health South Florida

    RECRUITING

    Coral Gables, Florida, 33143, United States

    Contact

  • The University of Vermont Medical Center

    RECRUITING

    Burlington, Vermont, 05401, United States

    Contact

  • University of Pennsylvania Medical Center

    RECRUITING

    Pittsburgh, Pennsylvania, 15213, United States

    Contact

Conditions

Explore the condition pages connected to this study.